Evan C. Unger Receives Radiology Editor's Recognition Award MVTFeb 10, 20220 min readUnger, Evan C Award 20222.pdfDownload PDF • 192KB
MVT Reports Breakthrough Preclinical Results for MVT‑101 in DVT ModelPhase‑shift microbubble (also known as nanobubble) technology demonstrates robust thrombus resolution in a porcine deep vein thrombosis (DVT) model. Salt Lake City, UT – Microvascular Therapeutics, In
Microvascular Therapeutics Showcases Breakthrough Ultrasound Contrast Agent, MVT-100, at the 2025 ICUS Bubble ConferenceChicago, IL – October 7th, 2025 – Microvascular Therapeutics (MVT), a clinical-stage biopharmaceutical company pioneering innovations in...
Microvascular Therapeutics, Inc Named 2025 Most Fundable Company® by Pepperdine Graziadio Business SchoolSalt Lake City (Utah), September 29, 2025: Microvascular Therapeutics (MVT), the leader in development of next-generation ultrasound...
Comments